Table 3 Subgroup analysis for lockdown and non-lockdown comparison.
Parameter | Subgroups | COVID lockdown | P-value | |
|---|---|---|---|---|
Yes | No | |||
Age |  | 50.68 ± 16.43 | 50.98 ± 18.33 | 0.948 |
Gender | Male | 19 (55.9%) | 139 (66.2%) | 0.243 |
Female | 15 (44.1%) | 71 (33.8%) | ||
Etiology | Idiopathic | 31 (91.2%) | 172 (81.9%) | 0.366 |
Traumatic | 2 (5.9%) | 20 (9.5%) | ||
Post-surgical | 1 (2.9%) | 18 (8.6%) | ||
Macula involvement | On | 5 (14.7%) | 32 (15.2%) | 0.857 |
Off | 27 (79.4%) | 168 (80.0%) | ||
Partially off | 2 (5.9%) | 10 (4.8%) | ||
Involved quadrants | 1 quadrant | 0 (0.0%) | 19 (9.0%) | 0.163 |
2 quadrants | 9 (26.5%) | 72 (34.3%) | ||
3 quadrants | 9 (26.5%) | 55 (26.2%) | ||
All quadrants | 16 (47.0%) | 64 (30.5%) | ||
Lens status | Phakic | 26 (76.5%) | 125 (59.5%) | 0.215 |
Pseudophakic | 7 (20.6%) | 75 (35.7%) | ||
Aphakic | 1 (2.9%) | 10 (4.8%) | ||
PVR | No PVR | 14 (41.2%) | 116 (55.2%) | 0.381 |
PVR-A | 1 (2.9%) | 3 (1.4%) | ||
PVR-B | 2 (5.9%) | 6 (2.9%) | ||
PVR-CA | 10 (29.4%) | 40 (19.1%) | ||
PVR-CP | 7 (20.6%) | 45 (21.4%) | ||
Break position | Anterior to equator | 23 (67.6%) | 149 (71.0%) | 0.845 |
Posterior to equator | 11 (32.4%) | 61 (29.0%) | ||
Choroidal detachment | Yes | 1 (2.9%) | 9 (4.3%) | 0.718 |
No | 33 (97.1%) | 201 (95.7%) | ||
Anesthesia type | General anesthesia | 31 (91.2%) | 168 (80.0%) | 0.119 |
Sedation and local anesthesia | 3 (8.8%) | 42 (20.0%) | ||
Primary surgery | PPV + SO | 15 (44.1%) | 118 (56.2%) | 0.570 |
SB | 14 (41.2%) | 69 (32.9%) | ||
Phacoemulsification + PPV | 5 (14.7%) | 22 (10.5%) | ||
Pneumatic retinopexy | 0 (0.0%) | 1 (0.5%) | ||
Secondary surgery for anatomically attached retina | SOR | 16 (47.1%) | 78 (37.1%) | 0.942 |
SOR + phaco | 15 (44.1%) | 35 (16.7%) | ||
ERM | 0 (0.0%) | 2 (0.9%) | ||
ERM + phaco | 1 (2.9%) | 2 (0.9%) | ||
Secondary surgery for primary treatment failure at 6 months | PPV revision | 7 (20.6%) | 35 (16.7%) | 0.951 |
SB | 1 (2.9%) | 4 (1.9%) | ||
